Brain injury in adenosine Al receptor knock-out mice after pentetrazole kindling and its correlation with COX-2

National Medical Journal of China

Volumn 89, Issue 37, 2009, Pages 2634-2638

  Kang, Hui Cong ^a   Xu, Feng ^a   Liu, Xiao Yan ^a   Hu, Qi ^a   Liu, Yan ^a   Tang, Kun ^a   Li, Xiang ^a   Wang, Yuan ^a   Liu, Zhi Guang ^a   Zhu, Sui Qiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Al receptor knock out mice; Apoptosis; Caspase 3; Cyclooxygenase 2

Indexed keywords

ADENOSINE A1 RECEPTOR; CASPASE 3; CYCLOOXYGENASE 2; PENTETRAZOLE;

ANIMAL; APOPTOSIS; ARTICLE; CYTOLOGY; DRUG EFFECT; HIPPOCAMPUS; KINDLING; METABOLISM; MOUSE; MOUSE MUTANT;

ANIMALS; APOPTOSIS; CASPASE 3; CYCLOOXYGENASE 2; HIPPOCAMPUS; KINDLING, NEUROLOGIC; MICE; MICE, KNOCKOUT; PENTYLENETETRAZOLE; RECEPTOR, ADENOSINE A1;

EID: 84871433208     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.37.011     Document Type: Article

References (13)

1. Pagonopoulou O, Efthimiadou A, Asimakopoulos B, et al. Modulatory role of adenosine and its receptors in epilepsy: possible therapeutic approaches. Neurosci Res, 2006, 56: 14-20.
2. Ribeiro JA, Sebastiao AM, de Mendonija A. Adenosine receptors in the nervous system: pathophysiological implications. Progress in Neurobiology, 2002, 68: 377-392.
3. Pohle W, Becker A, Grecksch G, et al. Piracetam prevents pentylenetet razol kindling induced neuronal loss and learning deficits. Seizure, 1997, 6: 467-474.
4. Mubagwa K, Flameng W. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res, 2001, 52: 25-39.
5. Fedele DE, Li T, Lan JQ, et al. Adenosine Al receptors are crucial in keeping an epileptic focus localized. Exp Neurol, 2006, 200: 184-190.
6. Mazumder S, Plesca D, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol, 2008, 414: 13-21.
7. Niquet J, Auvin S, Archie M, et al. Status epilepticus triggers caspase-3 activation and necrosis in the immature rat brain. Epilepsia, 2007, 48: 1203-1206.
8. Tokuhara D, Sakuma S, Hattori H, et al. Kainic acid dose affects delayed cell death mechanism after status epilepticus. Brain Dev, 2007, 29: 2-8.
9. Ho L, Osaka H, Aisen PS, et al. Induction of cyclooxygenase (COX)-2 but not COX-1 gene expression in apoptotic cell death. Neuroimmunol, 1998, 89: 142-149.
10. Voutsinos-Porche B, Koning E, Kaplan H, et al. Temporal patterns of the cerebral inflammatory response in the rat lithium- pilocarpine model of temporal lobe epilepsy. Neurobiol Dis, 2004, 17: 385-402.
11. Takako T, Kyoko S, Hiroko S, et al. Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling. Prostaglandins & Other Lipid Mediators, 2003, 71(3-4): 205-216.
12. Hewett SJ, Uliasz TF, Vidwans AS, et al. Cyclooxygenase-2 contributes to N-methyl- d-aspartate-mediated neuronal cell death in primary cortical cell culture. Pharmacol Exp Ther, 2000, 293: 417-425.
13. Kiran KA, Ashish D, Kulkarni SK. Rofecoxib, a selective cyclooxy- genase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: Possible involvement of adenosinergic mechanism. Epilepsy Research, 2008, 78: 60-70.